|
CA2890981C
(en)
|
2012-11-08 |
2022-07-05 |
Bristol-Myers Squibb Company |
Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn.alpha. responses
|
|
SG11201503397YA
(en)
*
|
2012-11-08 |
2015-05-28 |
Bristol Myers Squibb Co |
Heteroaryl substituted pyridyl compounds useful as kinase modulators
|
|
SG11201503395TA
(en)
|
2012-11-08 |
2015-05-28 |
Bristol Myers Squibb Co |
ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα
|
|
TWI582077B
(zh)
|
2013-11-07 |
2017-05-11 |
必治妥美雅史谷比公司 |
作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物
|
|
EP3080131B1
(en)
|
2013-12-10 |
2018-10-10 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
|
|
TW201609693A
(zh)
|
2014-01-03 |
2016-03-16 |
必治妥美雅史谷比公司 |
雜芳基取代之菸鹼醯胺化合物
|
|
WO2016001341A1
(en)
*
|
2014-07-03 |
2016-01-07 |
F. Hoffmann-La Roche Ag |
Sulfonylaminopyridine compounds, compositions and methods of use
|
|
WO2016022626A1
(en)
*
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
|
AR105114A1
(es)
|
2015-06-24 |
2017-09-06 |
Bristol Myers Squibb Co |
Compuestos de aminopiridina sustituida con heteroarilo
|
|
TW201718571A
(zh)
|
2015-06-24 |
2017-06-01 |
必治妥美雅史谷比公司 |
經雜芳基取代之胺基吡啶化合物
|
|
UY36749A
(es)
|
2015-06-24 |
2016-12-30 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Compuestos de aminopiridina sustituida con heteroarilo como inhibidores de quinasa y moduladores de irak-4, y composiciones farmacéuticas que los contienen
|
|
US10570096B2
(en)
*
|
2015-11-26 |
2020-02-25 |
Novartis Ag |
Diamino pyridine derivatives
|
|
CN115448916A
(zh)
*
|
2016-10-14 |
2022-12-09 |
林伯士拉克许米公司 |
Tyk2抑制剂及其用途
|
|
CN110300590A
(zh)
|
2016-10-21 |
2019-10-01 |
林伯士拉克许米公司 |
Tyk2抑制剂及其用途
|
|
US10294256B2
(en)
*
|
2016-12-13 |
2019-05-21 |
Bristol-Myers Squibb Company |
Phosphine oxide alkyl amide substituted heteroaryl compounds as modulators of IL-12, IL-23 and/or IFN alpha responses
|
|
TWI868528B
(zh)
|
2017-03-08 |
2025-01-01 |
日商武田藥品工業股份有限公司 |
Ｔｙｋ２抑制劑之生產方法
|
|
KR102604900B1
(ko)
|
2017-05-11 |
2023-11-21 |
브리스톨-마이어스 스큅 컴퍼니 |
Irak4 억제제로서 유용한 티에노피리딘 및 벤조티오펜
|
|
TWI776810B
(zh)
*
|
2017-05-12 |
2022-09-11 |
瑞士商諾華公司 |
新穎二胺基吡啶衍生物
|
|
ES2994013T3
(en)
|
2017-07-28 |
2025-01-15 |
Takeda Pharmaceuticals Co |
Tyk2 inhibitors and uses thereof
|
|
CN111315737B
(zh)
*
|
2017-11-21 |
2024-06-18 |
百时美施贵宝公司 |
经砜吡啶烷基酰胺取代的杂芳基化合物
|
|
IL315310A
(en)
*
|
2017-12-26 |
2024-10-01 |
Kymera Therapeutics Inc |
Irak degraders and uses thereof
|
|
EP3737666A4
(en)
|
2018-01-12 |
2022-01-05 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADATION AGENTS AND ASSOCIATED USES
|
|
WO2019160875A1
(en)
|
2018-02-13 |
2019-08-22 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: soluble salts and aqueous formulations of pyronins
|
|
WO2019160873A1
(en)
|
2018-02-13 |
2019-08-22 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: o-alkyl-deuterated pyronins
|
|
WO2019173507A1
(en)
|
2018-03-06 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents : arylalkylcarboxamido phloroglucinols
|
|
JP6557436B1
(ja)
|
2018-03-12 |
2019-08-07 |
アッヴィ・インコーポレイテッド |
チロシンキナーゼ２媒介性シグナル伝達の阻害剤
|
|
CN111936486B
(zh)
*
|
2018-03-22 |
2023-09-22 |
百时美施贵宝公司 |
用作IL-12、IL-23和/或IFNα响应的调节剂的包含吡啶的杂环化合物
|
|
US12454520B2
(en)
|
2018-07-06 |
2025-10-28 |
Kymera Therapeutics, Inc. |
Protein degraders and uses thereof
|
|
AU2019360941B2
(en)
|
2018-10-15 |
2025-02-27 |
Takeda Pharmaceutical Company Limited |
TYK2 inhibitors and uses thereof
|
|
WO2020092196A1
(en)
*
|
2018-10-30 |
2020-05-07 |
Bristol-Myers Squibb Company |
Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of il-12, il-23 and/or ifn-alpha
|
|
US11053241B2
(en)
|
2018-11-30 |
2021-07-06 |
Nimbus Lakshmi, Inc. |
TYK2 inhibitors and uses thereof
|
|
BR112021010484A2
(pt)
|
2018-11-30 |
2021-08-24 |
Kymera Therapeutics, Inc. |
Degradadores de irak e usos dos mesmos
|
|
AU2020212001A1
(en)
|
2019-01-23 |
2021-07-22 |
Takeda Pharmaceutical Company Limited |
TYK2 inhibitors and uses thereof
|
|
CN115448910B
(zh)
*
|
2019-01-28 |
2024-04-19 |
江苏豪森药业集团有限公司 |
一种哒嗪类衍生物抑制剂、其制备方法和应用
|
|
JP7570399B2
(ja)
|
2019-07-18 |
2024-10-21 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｉｒａｋ４阻害剤として有用な三環式ヘテロアリール化合物
|
|
EP3999512B1
(en)
|
2019-07-18 |
2023-08-23 |
Bristol-Myers Squibb Company |
Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as irak4 inhibitors
|
|
EP4004000B1
(en)
|
2019-07-23 |
2025-07-09 |
Bristol-Myers Squibb Company |
Thienopyridinyl and thiazolopyridinyl compounds useful as irak4 inhibitors
|
|
EP4010317B1
(en)
|
2019-08-06 |
2024-06-19 |
Bristol-Myers Squibb Company |
Bicyclic heterocyclic compounds useful as irak4 inhibitors
|
|
AU2020347274A1
(en)
|
2019-09-13 |
2022-03-31 |
Nimbus Saturn, Inc. |
HPK1 antagonists and uses thereof
|
|
US12391702B2
(en)
|
2020-02-03 |
2025-08-19 |
Bristol-Myers Squibb Company |
Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as IRAK4 inhibitors
|
|
CN115335380B
(zh)
|
2020-02-03 |
2024-08-02 |
百时美施贵宝公司 |
可用作irak4抑制剂的三环杂芳基化合物
|
|
CN112203515B
(zh)
*
|
2020-03-11 |
2022-08-02 |
西北农林科技大学 |
N-苄基苯甲酰胺类化合物作为除草剂的用途
|
|
JP2023522195A
(ja)
*
|
2020-04-14 |
2023-05-29 |
ゴッサマー バイオ サービシズ、インコーポレイテッド |
炎症性疾患の治療のための置換ピリジン
|
|
WO2021222153A1
(en)
*
|
2020-04-28 |
2021-11-04 |
Bristol-Myers Squibb Company |
Substituted n-(methyl-d3)pyridazine-3-carboxamide or n-(methyl-d3)-nicotinamide compounds as il-12, il-23 and/or ifnalpha modulators
|
|
JP7537002B2
(ja)
*
|
2020-08-07 |
2024-08-20 |
南京薬石科技股▲フン▼有限公司 |
Ｃｄｋ９阻害剤およびその使用
|
|
CN114181257B
(zh)
*
|
2020-09-14 |
2025-02-14 |
四川科伦博泰生物医药股份有限公司 |
吡啶类化合物，包含其的药物组合物，其制备方法及其用途
|
|
WO2022087634A1
(en)
|
2020-10-23 |
2022-04-28 |
Nimbus Clotho, Inc. |
Ctps1 inhibitors and uses thereof
|
|
WO2022133046A2
(en)
*
|
2020-12-16 |
2022-06-23 |
Ifm Due, Inc. |
Compounds and compositions for treating conditions associated with sting activity
|
|
CN116867758A
(zh)
|
2020-12-30 |
2023-10-10 |
凯麦拉医疗公司 |
Irak降解剂和其用途
|
|
AU2022215844A1
(en)
|
2021-02-02 |
2023-09-14 |
Liminal Biosciences Limited |
Gpr84 antagonists and uses thereof
|
|
MX2023009060A
(es)
|
2021-02-02 |
2023-09-29 |
Liminal Biosciences Ltd |
Antagonistas de gpr84 y usos de estos.
|
|
JP2024506909A
(ja)
|
2021-02-12 |
2024-02-15 |
ニンバス サターン， インコーポレイテッド |
Ｈｐｋ１アンタゴニスト及びその使用
|
|
AU2022220043A1
(en)
|
2021-02-15 |
2023-08-31 |
Kymera Therapeutics, Inc. |
Irak4 degraders and uses thereof
|
|
JP2024508794A
(ja)
*
|
2021-02-19 |
2024-02-28 |
スドー バイオサイエンシーズ リミテッド |
Ｔｙｋ２阻害剤およびその使用
|
|
WO2022175746A1
(en)
*
|
2021-02-19 |
2022-08-25 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
CA3207819A1
(en)
*
|
2021-02-19 |
2022-08-25 |
Anjali Pandey |
Tyk2 inhibitors and uses thereof
|
|
US20240189309A1
(en)
*
|
2021-02-19 |
2024-06-13 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
US11926625B2
(en)
|
2021-03-05 |
2024-03-12 |
Nimbus Saturn, Inc. |
HPK1 antagonists and uses thereof
|
|
WO2022213062A1
(en)
|
2021-03-29 |
2022-10-06 |
Nimbus Saturn, Inc. |
Hpk1 antagonists and uses thereof
|
|
BR112023020781A2
(pt)
|
2021-04-09 |
2023-12-19 |
Nimbus Clio Inc |
Moduladores de cbl-b e usos dos mesmos
|
|
KR20240111312A
(ko)
|
2021-10-25 |
2024-07-16 |
카이메라 쎄라퓨틱스 인코포레이티드 |
Tyk2 분해제 및 이의 용도
|
|
WO2023076556A1
(en)
|
2021-10-29 |
2023-05-04 |
Kymera Therapeutics, Inc. |
Irak4 degraders and synthesis thereof
|
|
CA3240888A1
(en)
|
2021-12-16 |
2023-06-22 |
Lynk Pharmaceuticals Co. Ltd. |
Tyk2 inhibitors and compositions and methods thereof
|
|
WO2023108536A1
(en)
*
|
2021-12-16 |
2023-06-22 |
Lynk Pharmaceuticals Co. Ltd. |
Tyk2 inhibitors and compositions and methods thereof
|
|
WO2023147594A2
(en)
|
2022-01-31 |
2023-08-03 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
|
CN116693449A
(zh)
|
2022-03-04 |
2023-09-05 |
上海致根医药科技有限公司 |
用作tyk2抑制剂的化合物、其制备方法及其在医药上的应用
|
|
AU2023255386A1
(en)
*
|
2022-04-19 |
2024-10-31 |
Blueprint Medicines Corporation |
Kit inhibitors
|
|
EP4532485A1
(en)
*
|
2022-05-27 |
2025-04-09 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
WO2024028364A1
(en)
|
2022-08-02 |
2024-02-08 |
Liminal Biosciences Limited |
Aryl-triazolyl and related gpr84 antagonists and uses thereof
|
|
EP4565568A1
(en)
|
2022-08-02 |
2025-06-11 |
Liminal Biosciences Limited |
Heteroaryl carboxamide and related gpr84 antagonists and uses thereof
|
|
AU2023317742A1
(en)
|
2022-08-02 |
2025-03-20 |
Liminal Biosciences Limited |
Substituted pyridone gpr84 antagonists and uses thereof
|
|
CN121194786A
(zh)
*
|
2023-06-02 |
2025-12-23 |
Idrx股份有限公司 |
用于治疗癌症的包含kit抑制剂的组合疗法
|
|
TW202529769A
(zh)
|
2023-09-21 |
2025-08-01 |
日商武田藥品工業股份有限公司 |
Ｔｙｋ２抑制劑及其用途
|